BSE
Your Result on : Company News
Aurobindo Pharma Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524804
ISIN Demat
INE406A01037
Book Value (Rs)
391.1437121
NSE Symbol
AUROPHARMA
Divident Yield %
0.26
Market Cap
(Rs In Cr.)
89,957
P/E (TTM)
37.04
EPS (TTM)
41.81
Face Value
(Rs)
1
Date Heading
29-Jun-26 Aurobindo Pharma's API unit clears USFDA inspection with two observati
27-Jun-26 USFDA inspects Auroactive Pharma's manufacturing unit in Andhra Pradesh
27-Jun-26 Aurobindo Pharma's API unit clears USFDA inspection with two observati
22-Jun-26 Aurobindo Pharma USA receives US FTC approval for acquisition of Lanne
22-Jun-26 Aurobindo Pharma receives FTC nod for $250 million acquisition of Lann
19-Jun-26 Aurobindo Pharma receives US FTC approval for acquisition of Lannett b
19-Jun-26 Aurobindo Pharma Ltd up for third straight session
15-Jun-26 Aurobindo Pharma slides after USFDA classifies Eugia Unit-III as OAI
15-Jun-26 Aurobindo Pharma Ltd leads losers in 'A' group
13-Jun-26 Aurobindo Pharma's Eugia Unit-III receives OAI classification from USF
05-Jun-26 Aurobindo Pharma gains after receiving USFDA approval for Tofacitinib
04-Jun-26 Aurobindo Pharma receives USFDA approval for Tofacitinib Tablets
25-May-26 USFDA classifies Eugia Pharma Specialities' Telangana unit inspection
22-May-26 Aurobindo Pharma consolidated net profit rises 1.97% in the March 2026
22-May-26 Suraksha Diagnostic Ltd Falls 7.95%
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)